# AETERNUM HEALTH, INC. (AETN) · Edgar & Edgarette company card

> Aeternum Health (AETN) grew revenue 213% in FY2025 to $0 million, operating margin -132% against a -7.6% median for miscellaneous electrical machinery, equipment & supplies, equity -3664% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 764630 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/AETN) · [JSON](https://www.pops4.com/boards/company/AETN.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $203,655 |
| Revenue growth, 1 year | 212.7% |
| Revenue growth per year | 118.0% |
| Operating margin | -132.2% (prior year -661.1%) |
| Net margin | -165.5% |
| Operating cash flow | −$2,958 |
| Capital spending | — |
| Free cash flow | — |
| Cash | $0 |
| Long-term debt | — |
| Total assets | $54,557 |
| Total equity | −$2M |
| Equity ÷ assets | -3663.8% |
| Return on equity | — |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: -359.96 (distress zone)
- Piotroski F: 5 of 9 (middling)
- Health Harbor boat: Rotting at the dock · four or more warning signs · filed late quarterly report notice in the last 12 months; liabilities exceed assets (often from years of share buybacks, not always distress); operating cash flow was negative (-$3K in FY2025); operating loss: a margin of -132.2% in FY2025; revenue is hard to predict: its 80% range is ±53%

## Edgarette's reading

Exposure: revenue $204K (FY2025). Experience: revenue up 212.7% on the year, up 118.0% a year over 3 years; operating margin -132.2%, up from -661.1%. Soundness: equity -3663.8% of assets (liabilities exceed assets). Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $294K and $950K next year (method v4.1: its own 1-year record of growth weighed at 0% against under $50M filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $272K to $1.0M. A statistical range, not company guidance. Against peers (15 filers, $50M+ revenue, miscellaneous electrical machinery, equipment & supplies): operating margin -132.2% against a -7.6% median; growth 212.7% against 6.9%.

Range logged 2026-09-28, receipt cf7b5fc6bf5322dc, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item NT 10-Q Late quarterly report notice: 2, latest 2026-08-14 ([filing](https://www.sec.gov/Archives/edgar/data/764630/000149315226038480/0001493152-26-038480-index.htm))
- Item 5.02 Director or officer change: 3, latest 2026-09-01 ([filing](https://www.sec.gov/Archives/edgar/data/764630/000149315226040954/0001493152-26-040954-index.htm))

## Recent filings

- 8-K · filed 2026-09-25 · 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/764630/000149315226044256/0001493152-26-044256-index.htm)
- 8-K · filed 2026-09-01 · 5.02 Departure or Election of Directors; Appointment of Officers; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/764630/000149315226040954/0001493152-26-040954-index.htm)
- 10-Q · filed 2026-08-19 · [filing](https://www.sec.gov/Archives/edgar/data/764630/000149315226039164/0001493152-26-039164-index.htm)
- 8-K · filed 2026-08-13 · 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/764630/000149315226037609/0001493152-26-037609-index.htm)
- 8-K · filed 2026-07-07 · 2.01 Completion of Acquisition or Disposition of Assets; 3.02 Unregistered Sales of Equity Securities; 5.01 Changes in Control of Registrant; 5.02 Departure or Election of Directors; Appointment of Officers; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/764630/000149315226032365/0001493152-26-032365-index.htm)
- 10-Q · filed 2026-05-19 · [filing](https://www.sec.gov/Archives/edgar/data/764630/000149315226024377/0001493152-26-024377-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0000764630.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=764630

## Cite

POPS4, Edgar & Edgarette: AETERNUM HEALTH, INC. (AETN) company card, from the company's own SEC filings, accessed 2026-11-12, https://www.pops4.com/boards/company/AETN. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.